Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
We leverage the benefits of tirzepatide to help clients achieve their weight loss goals
Physiol Rev 97:721766
Tirzepatide is also available for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, when prescribed within specialist weight management services according to NICE criteria
In research settings, it has been observed to increase pigmentation and modulate central pathways influencing libido and appetite
Tirzepatide is actively studied in research on dual incretin receptor pharmacology, adipose tissue biology, beta-cell preservation, NASH resolution, obstructive sleep apnea, heart failure with preserved ejection fraction (HFpEF), and polycystic kidney disease
Together with your provider, establish attainable goals
US$ 29.77
US$ 28.27
US$ 26.81
US$ 23.13
US$ 27.32
